vs
Side-by-side financial comparison of Danaher Corporation (DHR) and DXC Technology Co (DXC). Click either name above to swap in a different company.
Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $3.2B, roughly 1.9× DXC Technology Co). Danaher Corporation runs the higher net margin — 17.3% vs 3.4%, a 13.9% gap on every dollar of revenue. On growth, Danaher Corporation posted the faster year-over-year revenue change (3.7% vs -1.0%). Danaher Corporation produced more free cash flow last quarter ($1.1B vs $359.0M). Over the past eight quarters, Danaher Corporation's revenue compounded faster (1.8% CAGR vs -2.9%).
Danaher CorporationDHREarnings & Financial Report
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...
DXC Technology Company is an American multinational information technology (IT) services and consulting company headquartered in Ashburn, Virginia.
DHR vs DXC — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $6.0B | $3.2B |
| Net Profit | $1.0B | $107.0M |
| Gross Margin | 60.3% | — |
| Operating Margin | 22.6% | 8.2% |
| Net Margin | 17.3% | 3.4% |
| Revenue YoY | 3.7% | -1.0% |
| Net Profit YoY | 7.9% | 87.7% |
| EPS (diluted) | $1.45 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.8B | $3.2B | ||
| Q3 25 | $6.1B | $3.2B | ||
| Q2 25 | $5.9B | $3.2B | ||
| Q1 25 | $5.7B | $3.2B | ||
| Q4 24 | $6.5B | $3.2B | ||
| Q3 24 | $5.8B | $3.2B | ||
| Q2 24 | $5.7B | $3.2B |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $107.0M | ||
| Q3 25 | $908.0M | $36.0M | ||
| Q2 25 | $555.0M | $16.0M | ||
| Q1 25 | $954.0M | $264.0M | ||
| Q4 24 | $1.1B | $57.0M | ||
| Q3 24 | $818.0M | $42.0M | ||
| Q2 24 | $907.0M | $26.0M |
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | — | ||
| Q3 25 | 58.2% | — | ||
| Q2 25 | 59.3% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | 59.5% | — | ||
| Q3 24 | 58.7% | — | ||
| Q2 24 | 59.7% | — |
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | 8.2% | ||
| Q3 25 | 19.1% | 8.0% | ||
| Q2 25 | 12.8% | 6.8% | ||
| Q1 25 | 22.2% | 7.3% | ||
| Q4 24 | 21.8% | 8.9% | ||
| Q3 24 | 16.5% | 8.6% | ||
| Q2 24 | 20.3% | 6.9% |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 17.5% | 3.4% | ||
| Q3 25 | 15.0% | 1.1% | ||
| Q2 25 | 9.3% | 0.5% | ||
| Q1 25 | 16.6% | 8.3% | ||
| Q4 24 | 16.6% | 1.8% | ||
| Q3 24 | 14.1% | 1.3% | ||
| Q2 24 | 15.8% | 0.8% |
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | $0.61 | ||
| Q3 25 | $1.27 | $0.20 | ||
| Q2 25 | $0.77 | $0.09 | ||
| Q1 25 | $1.32 | $1.42 | ||
| Q4 24 | $1.50 | $0.31 | ||
| Q3 24 | $1.12 | $0.23 | ||
| Q2 24 | $1.22 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.7B |
| Total DebtLower is stronger | — | $3.1B |
| Stockholders' EquityBook value | — | $3.1B |
| Total Assets | — | $13.2B |
| Debt / EquityLower = less leverage | — | 0.98× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | $3.1B | ||
| Q3 25 | $16.9B | $2.4B | ||
| Q2 25 | $17.4B | $3.1B | ||
| Q1 25 | $16.5B | $3.0B | ||
| Q4 24 | $16.0B | $3.6B | ||
| Q3 24 | $17.5B | $3.8B | ||
| Q2 24 | $17.0B | $3.8B |
| Q1 26 | — | — | ||
| Q4 25 | $52.5B | $3.1B | ||
| Q3 25 | $51.1B | $3.1B | ||
| Q2 25 | $52.3B | $3.2B | ||
| Q1 25 | $50.8B | $3.2B | ||
| Q4 24 | $49.5B | $3.0B | ||
| Q3 24 | $51.3B | $3.0B | ||
| Q2 24 | $49.9B | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | $83.5B | $13.2B | ||
| Q3 25 | $79.9B | $13.6B | ||
| Q2 25 | $81.6B | $13.4B | ||
| Q1 25 | $79.1B | $13.2B | ||
| Q4 24 | $77.5B | $13.0B | ||
| Q3 24 | $80.6B | $13.5B | ||
| Q2 24 | $78.6B | $13.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 0.98× | ||
| Q3 25 | 0.33× | 0.77× | ||
| Q2 25 | 0.33× | 0.98× | ||
| Q1 25 | 0.32× | 0.93× | ||
| Q4 24 | 0.32× | 1.22× | ||
| Q3 24 | 0.34× | 1.28× | ||
| Q2 24 | 0.34× | 1.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3B | $414.0M |
| Free Cash FlowOCF − Capex | $1.1B | $359.0M |
| FCF MarginFCF / Revenue | 18.2% | 11.2% |
| Capex IntensityCapex / Revenue | 4.0% | 1.7% |
| Cash ConversionOCF / Net Profit | 1.28× | 3.87× |
| TTM Free Cash FlowTrailing 4 quarters | $5.3B | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $414.0M | ||
| Q3 25 | $1.7B | $409.0M | ||
| Q2 25 | $1.3B | $186.0M | ||
| Q1 25 | $1.3B | $315.0M | ||
| Q4 24 | $2.0B | $650.0M | ||
| Q3 24 | $1.5B | $195.0M | ||
| Q2 24 | $1.4B | $238.0M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | $359.0M | ||
| Q3 25 | $1.4B | $365.0M | ||
| Q2 25 | $1.1B | $143.0M | ||
| Q1 25 | $1.1B | $238.0M | ||
| Q4 24 | $1.5B | $568.0M | ||
| Q3 24 | $1.2B | $154.0M | ||
| Q2 24 | $1.1B | $190.0M |
| Q1 26 | 18.2% | — | ||
| Q4 25 | 25.5% | 11.2% | ||
| Q3 25 | 22.6% | 11.5% | ||
| Q2 25 | 18.4% | 4.5% | ||
| Q1 25 | 18.4% | 7.5% | ||
| Q4 24 | 23.0% | 17.6% | ||
| Q3 24 | 21.0% | 4.8% | ||
| Q2 24 | 19.7% | 5.9% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | 1.7% | ||
| Q3 25 | 4.8% | 1.4% | ||
| Q2 25 | 4.2% | 1.4% | ||
| Q1 25 | 4.3% | 2.4% | ||
| Q4 24 | 7.9% | 2.5% | ||
| Q3 24 | 5.1% | 1.3% | ||
| Q2 24 | 5.0% | 1.5% |
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | 3.87× | ||
| Q3 25 | 1.83× | 11.36× | ||
| Q2 25 | 2.41× | 11.63× | ||
| Q1 25 | 1.36× | 1.19× | ||
| Q4 24 | 1.86× | 11.40× | ||
| Q3 24 | 1.85× | 4.64× | ||
| Q2 24 | 1.56× | 9.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DHR
Segment breakdown not available.
DXC
| GIS Segment | $1.6B | 50% |
| CES Segment | $1.3B | 40% |
| Insurance Segment | $321.0M | 10% |
